Presentation is loading. Please wait.

Presentation is loading. Please wait.

Volume 153, Issue 3, Pages e41-e43 (March 2018)

Similar presentations


Presentation on theme: "Volume 153, Issue 3, Pages e41-e43 (March 2018)"— Presentation transcript:

1 Volume 153, Issue 3, Pages e41-e43 (March 2018)
Sjögren Syndrome With Associated Lymphocytic Interstitial Pneumonia Successfully Treated With Tacrolimus and Abatacept as an Alternative to Rituximab  Grace Thompson, MBBS, Andrew Mclean-Tooke, MD, Jeremy Wrobel, MBBS, Melanie Lavender, MBChB, Michaela Lucas, MD  CHEST  Volume 153, Issue 3, Pages e41-e43 (March 2018) DOI: /j.chest Copyright © 2017 American College of Chest Physicians Terms and Conditions

2 Figure 1 B and T cells expressed as a percentage of total lymphocytes over time with treatments that included rituximab, tacrolimus, and abatacept. ABA = abatacept; RTX = rituximab; TAC = tacrolimus. CHEST  , e41-e43DOI: ( /j.chest ) Copyright © 2017 American College of Chest Physicians Terms and Conditions

3 Figure 2 Pulmonary function tests included FEV1, FVC, TLC, and KCO. Treatments included rituximab, tacrolimus, and abatacept. Hb = hemoglobin; KCO = carbon monoxide transfer coefficient; TLC = total lung capacity. See Figure 1 legend for expansion of other abbreviations. CHEST  , e41-e43DOI: ( /j.chest ) Copyright © 2017 American College of Chest Physicians Terms and Conditions


Download ppt "Volume 153, Issue 3, Pages e41-e43 (March 2018)"

Similar presentations


Ads by Google